NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00517-7504-25 — Acetylcysteine 10% solutionAI (465 hospitals, 55,363–56,488 samples)
• NDC 00093-6815-73 — Budesonide 0.25 mg/2 mL inhalation suspensionAI (456 hospitals, 55,487–56,486 samples)
• NDC 00143-9525-10 — Dexmedetomidine IV infusion in salineAI (295 hospitals, 54,965–56,486 samples)
• NDC 00487-9501-03 — Albuterol sulfate 2.5 mg nebulizer solutionAI (318 hospitals, 55,373–56,480 samples)
• NDC 00409-2066-10 — Lidocaine 2% numbing injectionAI (285 hospitals, 53,165–56,450 samples)
• NDC 63323-0695-04 — Acetylcysteine 10% solutionAI (403 hospitals, 55,358–56,438 samples)
• NDC 00378-8270-55 — Albuterol sulfate 2.5 mg nebulizer solutionAI (314 hospitals, 55,106–56,429 samples)
• NDC 71288-0505-03 — Dexmedetomidine 100 mcg/mL solution, 2 mL vialAI (402 hospitals, 55,355–56,408 samples)
• NDC 63323-0693-10 — Acetylcysteine solution, 10% vialAI (346 hospitals, 55,354–56,398 samples)
• NDC 43598-0169-58 — ENALAPRILAT 1.25 MG/ML INTRAVENOUS SOLUTIONAI (234 hospitals, 55,365–56,391 samples)
• NDC 00093-6815-45 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (268 hospitals, 55,344–56,388 samples)
• NDC 00703-2033-03 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (138 hospitals, 55,353–56,388 samples)
• NDC 00409-2053-10 — Ketamine 50 mg/mL injectionAI (232 hospitals, 54,993–56,379 samples)
• NDC 68180-0984-30 — Budesonide 0.5 mg/2 mL inhalation suspensionAI (331 hospitals, 55,352–56,378 samples)
• NDC 00487-9701-30 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (290 hospitals, 55,352–56,378 samples)
• NDC 00172-6406-49 — Cromolyn sodium 20 mg/2 mL nebulizer solutionAI (217 hospitals, 55,351–56,368 samples)
• NDC 63323-0367-11 — Polymyxin B antibiotic injection, 500,000 unitsAI (217 hospitals, 55,420–56,365 samples)
• NDC 47335-0703-48 — Albuterol sulfate nebulizer solutionAI (171 hospitals, 55,220–56,363 samples)
• NDC 54643-7862-01 — Multivitamin adult intravenous solution with vitamin KAI (126 hospitals, 55,420–56,356 samples)
• NDC 43598-0078-11 — Enalaprilat injection 1.25 mg/mLAI (300 hospitals, 55,213–56,347 samples)
• NDC 17478-0415-10 — Ephedrine sulfate injection, 50 mg per mLAI (153 hospitals, 55,418–56,345 samples)
• NDC 51754-0204-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (124 hospitals, 55,211–56,327 samples)
• NDC 70710-1643-07 — Verapamil hydrochloride injection, 2.5 mg per mLAI (355 hospitals, 55,011–56,325 samples)
• NDC 00409-3793-19 — Ketorolac 15 mg/mL injectionAI (312 hospitals, 53,630–56,321 samples)
• NDC 70092-1104-36 — Fentanyl and bupivacaine IV bagAI (256 hospitals, 55,338–56,319 samples)
• NDC 00409-3299-15 — Sodium acetate intravenous solutionAI (218 hospitals, 54,583–56,311 samples)
• NDC 00338-0519-09 — Plant-based (soy) intravenous fat emulsion 20%AI (391 hospitals, 55,345–56,308 samples)
• NDC 00409-4092-11 — Cupric chloride intravenous solutionAI (334 hospitals, 55,022–56,300 samples)
• NDC 51754-0203-04 — Verapamil injection 2.5 mg/mL vialAI (322 hospitals, 55,007–56,267 samples)
• NDC 00409-1144-02 — Verapamil hydrochloride injection, 2.5 mg/mLAI (356 hospitals, 55,006–56,266 samples)
• NDC 71288-0505-02 — Dexmedetomidine IV solution 200 mcg per 2 mLAI (355 hospitals, 55,220–56,264 samples)
• NDC 67457-0902-00 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (153 hospitals, 55,215–56,250 samples)
• NDC 00065-0800-50 — BSS Plus intraocular irrigation solutionAI (544 hospitals, 55,070–56,249 samples)
• NDC 00781-7296-85 — Albuterol sulfate inhaler (90 mcg per puff)AI (416 hospitals, 54,349–56,221 samples)
• NDC 63323-0463-01 — Bupivacaine with epinephrine numbing injectionAI (252 hospitals, 54,937–56,215 samples)
• NDC 00143-9251-01 — Rocuronium bromide injection, 100 mg per 10 mLAI (157 hospitals, 54,857–56,207 samples)
• NDC 55150-0236-20 — Vecuronium injection, 20 mg vialAI (272 hospitals, 55,328–56,201 samples)
• NDC 67457-0903-00 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (108 hospitals, 55,179–56,196 samples)
• NDC 14789-0012-02 — Sodium nitroprusside 25 mg/mL IV solutionAI (369 hospitals, 55,007–56,168 samples)
• NDC 00407-1413-66 — Iohexol 300 contrast dye injectionAI (114 hospitals, 54,355–56,155 samples)
• NDC 00409-9045-16 — Bupivacaine with epinephrine local anesthetic injectionAI (233 hospitals, 55,161–56,151 samples)
• NDC 00338-0017-41 — Dextrose 5% intravenous solutionAI (537 hospitals, 54,678–56,145 samples)
• NDC 76204-0021-60 — Concentrated saline solution for nebulizer inhalationAI (195 hospitals, 54,999–56,142 samples)
• NDC 00703-2914-03 — Vecuronium bromide 10 mg injectionAI (229 hospitals, 55,084–56,137 samples)
• NDC 63323-0424-10 — Flumazenil 0.1 mg/mL injection solutionAI (330 hospitals, 55,053–56,133 samples)
• NDC 70748-0175-01 — Arformoterol nebulizer solution, 15 mcg per 2 mLAI (186 hospitals, 55,006–56,113 samples)
• NDC 70756-0612-12 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (209 hospitals, 55,006–56,113 samples)
• NDC 70860-0103-41 — Polymyxin B sulfate injection, 500,000 unitsAI (130 hospitals, 55,136–56,108 samples)
• NDC 60687-0524-79 — Budesonide inhalation suspension 0.5 mg per 2 mLAI (538 hospitals, 55,063–56,107 samples)
• NDC 70069-0271-01 — Verapamil injection solution, 2.5 mg/mLAI (307 hospitals, 54,991–56,080 samples)